(Q37181697)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18523430%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Oxalate in renal stone disease: the terminal metabolite that just won't go away (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18523430%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18523430%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Susan R Marengo

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18523430%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

3 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18523430%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Nephrology

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18523430%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18523430%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18523430%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

368-377

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18523430%20AND%20SRC:MED&resulttype=core&format=json

Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

Reconstruction of human hepatocyte glyoxylate metabolic pathways in stably transformed Chinese-hamster ovary cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

Changing gender prevalence of stone disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Epidemiology of stone disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Renal function in patients with nephrolithiasis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Diabetes mellitus and hypertension associated with shock wave lithotripsy of renal and proximal ureteral stones at 19 years of followup

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

History of kidney stones as a possible risk factor for chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

High urinary calcium excretion and genetic susceptibility to hypertension and kidney stone disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Mechanism of formation of human calcium oxalate renal stones on Randall's plaque

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Hyperoxaluria in kidney stone formers treated with modern bariatric surgery

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Renal complications of jejuno-ileal bypass for obesity

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Chronic renal failure secondary to oxalate nephropathy: a preventable complication after jejunoileal bypass

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Hyperoxaluric calcium nephrolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Intestinal transport of an obdurate anion: oxalate

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Inhibition of oxalate synthesis: in vitro studies using analogues of oxalate and glycolate

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Characterization of oxalate transport by the human erythrocyte band 3 protein

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Contribution of dietary oxalate to urinary oxalate excretion

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

The SLC26 gene family of multifunctional anion exchangers

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Role of dietary intake and intestinal absorption of oxalate in calcium stone formation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

The stomach: a new and powerful oxalate absorption site in man

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Functional characterization of three novel tissue-specific anion exchangers SLC26A7, -A8, and -A9

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Ileal oxalate absorption and urinary oxalate excretion are enhanced in Slc26a6 null mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Influence of a low- and a high-oxalate vegetarian diet on intestinal oxalate absorption and urinary excretion

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Intestinal and renal handling of oxalate loads in normal individuals and stone formers.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Food oxalate: factors affecting measurement, biological variation, and bioavailability

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Renal lithiasis and nutrition.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Conjugated bile acid replacement therapy reduces urinary oxalate excretion in short bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Glycolate and glyoxylate metabolism in HepG2 cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Hydroxyproline ingestion and urinary oxalate and glycolate excretion.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Identification of missense, nonsense, and deletion mutations in the GRHPR gene in patients with primary hyperoxaluria type II (PH2).

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

High incidence of hyperoxaluria in generalized peroxisomal disorders

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Vitamin C. Biosynthesis, recycling and degradation in mammals

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Ascorbate increases human oxaluria and kidney stone risk

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Medical therapy of urolithiasis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Handling of oxalate by the rat kidney

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Fractional oxalate clearance in subjects with normal and impaired renal function

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Plasma oxalate concentration and oxalate distribution volume in patients with normal and decreased renal function

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Fate of circulating oxalate in rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Determination of oxalic acid clearance and plasma concentration by radioisotope infusion. Results in a family with hyperoxaluria

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Renal Elimination Kinetics and Plasma Half-Life of Oxalate in Man

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Renal and intestinal handling of oxalate following oxalate loading in rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Continuous infusion of oxalate by minipumps induces calcium oxalate nephrocalcinosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Determination of evolved 14CO2 in decarboxylase reactions with application to measurement of [14C]oxalic acid

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Physiological roles and regulation of mammalian sulfate transporters

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Specificity and regulation of renal sulfate transporters

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Oxalate secretion in the rat proximal tubule

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Kidney models of calcium oxalate stone formation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Oxalate transport in renal tubular cells from normal and stone-forming animals

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Transport of oxalate across the rabbit papillary surface epithelium

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Regulation of anion exchanger Slc26a6 by protein kinase C

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Transport of organic anions across the basolateral membrane of proximal tubule cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

NaSi-1 and Sat-1: structure, function and transcriptional regulation of two genes encoding renal proximal tubular sulfate transporters

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Mechanism of chloride permeation in the cystic fibrosis transmembrane conductance regulator chloride channel

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Gating of CFTR by the STAS domain of SLC26 transporters

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Factors increasing the risk for stone formation in adult patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

1 reference

7 January 2021

Oxaluria--the neglected stepchild of nephrolithiasis?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Oxalate and calcium excretion in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

The management of stone disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

A new theory on the formation of renal calculi

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Oxalic acid alters intracellular calcium in endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Changes in renal hemodynamics and urodynamics in rats with chronic hyperoxaluria and after acute oxalate infusion: role of free radicals

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Essential arterial hypertension and stone disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Cell injury associated calcium oxalate crystalluria

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Renal cell adaptation to oxalate

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Renal oxidative vulnerability due to changes in mitochondrial-glutathione and energy homeostasis in a rat model of calcium oxalate urolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Hyperoxaluria-induced oxidative stress and antioxidants for renal protection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Oxalate inhibits renal proximal tubule cell proliferation via oxidative stress, p38 MAPK/JNK, and cPLA2 signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Oxalate ions and calcium oxalate crystal-induced up-regulation of osteopontin and monocyte chemoattractant protein-1 in renal fibroblasts.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Oxalate stimulates IL-6 production in HK-2 cells, a line of human renal proximal tubular epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Renal prothrombin mRNA is significantly decreased in a hyperoxaluric rat model of nephrolithiasis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Microarray analysis of changes in renal phenotype in the ethylene glycol rat model of urolithiasis: potential and pitfalls

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Crystal retention in renal stone disease: a crucial role for the glycosaminoglycan hyaluronan?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Mechanisms mediating oxalate-induced alterations in renal cell functions

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

An animal model of calcium oxalate urolithiasis based on a cyclooxygenase 2 selective inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Oxalate is toxic to renal tubular cells only at supraphysiologic concentrations

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Renal calcinosis and stone formation in mice lacking osteopontin, Tamm-Horsfall protein, or both

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Renal calcification in mice homozygous for the disrupted type IIa Na/Pi cotransporter gene Npt2.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Renal calcium stones: insights from the control of bone mineralization

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Phosphatonins and the regulation of phosphate homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Regulation of renal ion transport by the calcium-sensing receptor: an update

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021

Nephrocalcinosis: molecular insights into calcium precipitation within the kidney.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0845

7 January 2021